Tag: ‘Pass on the Pink Pill – Or Pass Out’
Flibanserin’s ‘Effects’ Do Not Outweigh Harms, Review Finds
Despite concerns about the risk to benefit ratio, the FDA approved flibanserin (Addyi) to treat low female sexual desire in August. In a new...